Jefferies Maintains Buy on Inovio Pharmaceuticals, Raises Price Target to $8

Benzinga · 2d ago
Jefferies analyst Roger Song maintains Inovio Pharmaceuticals (NASDAQ:INO) with a Buy and raises the price target from $3 to $8.